secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2022-12-05T23:59:59+00:00
Accession:  0001549084-22-000075
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics acquires Parker HMC business for $10M, appoints Scott Davis as CEO
-------------------------------------------------------------------------------

- Acquired Parker Hannifin's Human Motion and Control business for $10M ($5M cash + $5M zero-coupon note payable quarterly over 4 years).
- Acquisition includes Indego lower-limb exoskeleton line, expanding Ekso's product portfolio into home and community use markets.
- Steven Sherman resigned as CEO; appointed Scott G. Davis (formerly President/COO) as CEO effective immediately.
- Sherman remains Chairman and becomes Executive Chair under a one-year employment agreement with $125k salary and RSU grant.
- Adds Vanderbilt University as a key commercial and research partner to support future product development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000154908422000075/0001549084-22-000075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000154908422000075/ekso-20221205.htm
  HTML page:      https://secwatch.observer/filing/0001549084-22-000075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer